Session 2: Debate: Neoadjuvant Combined Immunotherapy vs Chemotherapy for MSI-H Locally Resectable Gastric or Gastroesophageal Junction Adenocarcinoma (GAC/GEJAC) - Discussion

Moderator(s)

• 

  Cathy Eng, MD, FACP, FASCO

  Vanderbilt-Ingram Cancer Center
  MD Anderson Cancer Center
• 

  Jordan D. Berlin, MD

  Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Panelist(s)

• 

  Yelena Y. Janjigian, MD

  Memorial Sloan Kettering Cancer Center
• 

  Anup Kasi, MD, MPH

  Kansas University Cancer Center